Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • active pharmaceutical...

    Tag: active pharmaceutical ingredients

    You Searched For "active-pharmaceutical-ingredients"
    Indias dependence on pharma imports from China: Minister informs parliament

    India's dependence on pharma imports from China: Minister informs parliament

    Medical Dialogues Bureau17 March 2020 10:20 AM GMT
    Delhi: Through a written reply in the Lok Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament about the...
    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Medical Dialogues Bureau14 March 2020 9:33 AM GMT
    Delhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that...
    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Morepen Labs adds blockbuster Rivaroxaban, Vildagliptin, UDCA to API portfolio

    Farhat Nasim14 Oct 2019 8:06 AM GMT
    While two products Rivaroxaban and Vildagliptin will augment Morepen Lab's presence in the cardiac and diabetic segments respectively, the third...
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA

    Medical Dialogues Bureau11 Oct 2019 4:30 AM GMT
    "The responsibilities and procedures applicable to the quality control unit are not fully followed. Several lists of documents requested were either...
    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by Wholesalers

    Meghna A Singhania27 Sep 2019 6:49 AM GMT
    New Delhi : Taking into consideration, the proposal on measures need to be taken to address the issue of repacking of Active Pharmaceutical...
    Biocon inks license, supply pact with CMS for 3 generic formulations

    Biocon inks license, supply pact with CMS for 3 generic formulations

    Medical Dialogues Bureau13 Sep 2019 9:15 AM GMT
    Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    Medical Dialogues Bureau29 Aug 2019 10:40 AM GMT
    New Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
    CDSCO preparing list of dual-use APIs imported from unregistered firms

    CDSCO preparing list of dual-use APIs imported from unregistered firms

    Medical Dialogues Bureau26 Aug 2019 8:53 AM GMT
    "The Central Drugs Standard Control Organisation (CDSCO), the Ministry of Health and the Department of Pharmaceuticals want to put a stop to the...
    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 4:32 AM GMT
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy

    Medical Dialogues Bureau8 July 2019 8:02 AM GMT
    As part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Alchem solves stability dilemma for micronized DIGOXIN; files PATENT for novel production process

    Meghna A Singhania16 April 2019 11:17 AM GMT
    Alchem's molecule is the sole micronized digoxin available globally that resolves the challenge of micro dosage formulation and the long-term...
    Over 75 percent of Indian drug import comes from China says pharma body IPCA

    Over 75 percent of Indian drug import comes from China says pharma body IPCA

    Ruby Khatun Khatun21 Dec 2017 4:00 AM GMT
    New Delhi: An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok